TIAA Trust, National Association
LXRX icon

TIAA Trust, National Association’s Lexicon Pharmaceuticals LXRX Stock Holding History

TIAA Trust, National Association’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$23K – 553
2025
Q4 		$23K Hold
20,000
– – ﹤0.01% 679
2025
Q3 		$27K Hold
20,000
– – ﹤0.01% 685
2025
Q2 		$18.9K Hold
20,000
– – ﹤0.01% 639
2025
Q1 		$9.22K Hold
20,000
– – ﹤0.01% 635
2024
Q4 		$14.8K Sell
20,000
-7,057
-26% -$8.51K ﹤0.01% 649
2024
Q3 		$42.5K Hold
27,057
– – ﹤0.01% 642
2024
Q2 		$45.5K Hold
27,057
– – ﹤0.01% 629
2024
Q1 		$64.9K Buy
27,057
+57
+0.2% +$122 ﹤0.01% 618
2023
Q4 		$41.3K Hold
27,000
– – ﹤0.01% 583
2023
Q3 		$29.4K Buy
+27,000
New +$47.4K ﹤0.01% 576

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TIAA Trust, National Association's LXRX Position: Q1 2026 in Review

TIAA Trust, National Association sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 20,000 shares — an estimated $23K sold.

TIAA Trust, National Association first reported a position in LXRX in Q3 2023 and held it in 10 quarters. The position peaked at $64.9K in Q1 2024. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • TIAA Trust, National Association reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 20,000 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $23K.
  • TIAA Trust, National Association first reported a position in Lexicon Pharmaceuticals in Q3 2023 and held it in 10 quarters.
  • TIAA Trust, National Association's Lexicon Pharmaceuticals position peaked at $64.9K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.